| ISIN | LU0432979614 |
|---|---|
| Valor Number | 10261626 |
| Bloomberg Global ID | |
| Fund Name | JPM Global Healthcare Fund A acc USD |
| Fund Provider |
J.P. Morgan Bank Luxembourg S.A.
6, route de Trèves L-2633, Senningerberg Grand Duchy of Luxembourg |
| Fund Provider | J.P. Morgan Bank Luxembourg S.A. |
| Representative in Switzerland |
JPMorgan Asset Management (Switzerland) LLC Genève Phone: +41 22 744 11 11 |
| Distributor(s) |
JP Morgan Asset Management (Europe) Sàrl Senningerberg Phone: +352 34 10 1 |
| Asset Class | Equities |
| EFC Category | Equity Health Care |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | To achieve a return by investing primarily in pharmaceutical, biotechnology, healthcare services, medical technology and life sciences companies ("Healthcare Companies"), globally. |
| Peculiarities |
| Current Price * | 508.18 USD | 28.10.2025 |
|---|---|---|
| Previous Price * | 506.03 USD | 27.10.2025 |
| 52 Week High * | 514.47 USD | 11.11.2024 |
| 52 Week Low * | 437.54 USD | 15.05.2025 |
| NAV * | 508.18 USD | 28.10.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 3,560,519,139 | |
| Unit/Share Assets *** | 921,346,660 | |
| Trading Information SIX | ||
| YTD Performance | +8.58% |
31.12.2024 - 28.10.2025
31.12.2024 28.10.2025 |
|---|---|---|
| YTD Performance (in CHF) | -4.91% |
31.12.2024 - 28.10.2025
31.12.2024 28.10.2025 |
| 1 month | +8.61% |
29.09.2025 - 28.10.2025
29.09.2025 28.10.2025 |
| 3 months | +9.16% |
28.07.2025 - 28.10.2025
28.07.2025 28.10.2025 |
| 6 months | +8.46% |
28.04.2025 - 28.10.2025
28.04.2025 28.10.2025 |
| 1 year | -1.13% |
28.10.2024 - 28.10.2025
28.10.2024 28.10.2025 |
| 2 years | +21.78% |
30.10.2023 - 28.10.2025
30.10.2023 28.10.2025 |
| 3 years | +11.15% |
28.10.2022 - 28.10.2025
28.10.2022 28.10.2025 |
| 5 years | +22.68% |
28.10.2020 - 28.10.2025
28.10.2020 28.10.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AbbVie Inc | 8.22% | |
|---|---|---|
| Johnson & Johnson | 7.83% | |
| Eli Lilly and Co | 6.56% | |
| AstraZeneca PLC | 4.72% | |
| Boston Scientific Corp | 3.92% | |
| Roche Holding AG | 3.85% | |
| Stryker Corp | 3.35% | |
| UnitedHealth Group Inc | 3.25% | |
| Danaher Corp | 3.15% | |
| CVS Health Corp | 2.88% | |
| Last data update | 30.09.2025 | |
| TER *** | 1.69% |
|---|---|
| TER date *** | 31.12.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.50% |
| Ongoing Charges *** | 1.69% |
|
SRRI ***
|
|
| SRRI date *** | 30.09.2025 |